carbidopa has been researched along with Coma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goldhammer, Y; Sadeh, M | 1 |
Haig, AJ; Ruess, JM | 1 |
Frigyesi, TL; Schwartz, R; Yahr, MD | 1 |
3 other study(ies) available for carbidopa and Coma
Article | Year |
---|---|
Extrapyramidal syndrome responsive to dopaminergic treatment following recovery from central pontine myelinolysis.
Topics: Basal Ganglia Diseases; Biperiden; Carbidopa; Chlorthalidone; Coma; Drug Therapy, Combination; Female; Humans; Hypertension; Hyponatremia; Levodopa; Lisuride; Middle Aged; Neurologic Examination; Parkinson Disease, Secondary; Pons; Quadriplegia; Saline Solution, Hypertonic; Tomography, X-Ray Computed | 1993 |
Recovery from vegetative state of six months' duration associated with Sinemet (levodopa/carbidopa).
Topics: Activities of Daily Living; Adult; Antiparkinson Agents; Brain Injuries; Carbidopa; Cognition; Coma; Drug Combinations; Humans; Levodopa; Male | 1990 |
Electrophysiological analysis of the effects of L-dopa on the reciprocal corticothalamic projections in the squirrel monkey. I. Iatrogenic coma and disinhibition of medial thalamic neurons.
Topics: Animals; Carbidopa; Caudate Nucleus; Coma; Dihydroxyphenylalanine; Disease Models, Animal; Electric Stimulation; Electroencephalography; Evoked Potentials; Haplorhini; Motor Cortex; Neural Inhibition; Neural Pathways; Thalamic Nuclei; Thalamus | 1974 |